← Back to Search

Lifestyle Education for Stroke Prevention

N/A
Waitlist Available
Led By Robert Dempsey, MD
Research Sponsored by University of Wisconsin, Madison
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
Prior carotid procedure altering ultrasound finding
Inability to participate in physical and exercise programs due to preexisting disability
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights
No Placebo-Only Group

Summary

This trial will develop a "Stroke Awareness Team" to provide education on the severity of the problem and how to change lifestyles to avoid strokes.

Who is the study for?
This trial is for members of the Oneida Nation receiving care through the Oneida Health Council Program, who are at high risk for stroke based on their medical history and lifestyle factors like hypertension, diabetes, smoking, and BMI. They must be willing to participate in a two-year follow-up. People with dementia, certain disabilities, illiteracy or conditions that prevent full participation are excluded.
What is being tested?
The study is testing a 'Stroke Awareness Team' approach versus standard therapies. High-risk individuals will receive either intensive coaching or standard care; low-risk individuals serve as controls without additional intervention. The program includes education on stroke prevention and healthy living events.
What are the potential side effects?
Since this trial focuses on education and lifestyle coaching rather than medication or invasive procedures, side effects are minimal but may include discomfort from lifestyle changes such as increased physical activity or dietary adjustments.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I've had a procedure on my carotid artery that affects ultrasound results.
Select...
I cannot join physical or exercise programs because of a disability I already have.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Incidence of Stroke or TIA
Change in Montreal Cognitive Assessment (MoCA) Vancouver Island Coastal First score
Change in Number of Participants that meet AHA Simple Rules for Blood Sugar
+8 more
Secondary study objectives
Change in Circulating Dipeptidyl Peptidase (DPPIV)
Change in Circulating Galectin3 (Gal-3)
Change in Plaque Area
+2 more
Other study objectives
Change in Serum microRNA
Compliance Rates

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Experimental Treatment
Group I: Low risk - controlExperimental Treatment1 Intervention
age ≥ 55 with LESS than three of the following risk factors: * History of TIA/Stroke * History of Coronary Artery disease * History of Hypertension and/or current elevated blood pressure * History of Diabetes * Current smoker * BMI ≥30
Group II: High Risk- intense coachingExperimental Treatment1 Intervention
age ≥ 55 with MORE than three of the following risk factors: * History of TIA/Stroke * History of Coronary Artery disease * History of Hypertension and/or current elevated blood pressure * History of Diabetes * Current smoker * BMI ≥30
Group III: High Risk - standard careExperimental Treatment1 Intervention
age ≥ 55 with MORE than three of the following risk factors: * History of TIA/Stroke * History of Coronary Artery disease * History of Hypertension and/or current elevated blood pressure * History of Diabetes * Current smoker * BMI ≥30

Find a Location

Who is running the clinical trial?

University of Wisconsin, MadisonLead Sponsor
1,234 Previous Clinical Trials
3,200,171 Total Patients Enrolled
16 Trials studying Stroke
271,166 Patients Enrolled for Stroke
Wisconsin Partnership ProgramOTHER
7 Previous Clinical Trials
338 Total Patients Enrolled
Robert Dempsey, MDPrincipal InvestigatorUniversity of Wisconsin, Madison

Media Library

High Risk - intensive coaching Clinical Trial Eligibility Overview. Trial Name: NCT04382963 — N/A
Stroke Research Study Groups: Low risk - control, High Risk - standard care, High Risk- intense coaching
Stroke Clinical Trial 2023: High Risk - intensive coaching Highlights & Side Effects. Trial Name: NCT04382963 — N/A
High Risk - intensive coaching 2023 Treatment Timeline for Medical Study. Trial Name: NCT04382963 — N/A
~14 spots leftby Jun 2025